Patrice Zeis

Co-Founder at GlioCART GmbH

Presenter

Dr. Patrice Zeis is Co-Founder and Chief Operating Officer of GlioCART GmbH, a Swiss biotechnology company developing a dual-action CAR-T therapy for glioblastoma. He leads corporate operations, financing and business development and coordinates CMC development with external partners. Working with academic, clinical and manufacturing collaborators, he is advancing GlioCART’s lead programme toward first-in-human clinical testing. At BIO-Europe, he is seeking strategic and financial partners to support GMP readiness, clinical development and the expansion of GlioCART’s cell-therapy pipeline.